-
value-based strategies to support patient access and payer engagement. Build foundational knowledge of U.S. market access strategy, including how payer, policy, reimbursement, and stakeholder dynamics
-
documents Modeling and Simulation Rotation: • Implement model informed drug development (MIDD) using quantitative approaches (e.g., population PK, PK/PD, optimal sample design) to address critical questions
-
· Participate in the development and execution of medical training plans · Help support the execution of omnichannel and digital strategy within Medical Affairs to ensure optimal orchestration of scientific
-
, and support the strategic dissemination of data that advances patient care worldwide. Through a phased training model, the program emphasizes both foundational knowledge and leadership development
-
clinical knowledge to enable efficient and effective drug development. Clinical Scientists contribute throughout the development cycle from Phase 1 to IND submission. They are data-driven, scientific leaders
-
will have a practical understanding of the other function’s responsibilities to enable them to be an optimal collaborator and colleague. During the fellowship, the fellow will work within Regulatory